Cell-mediated rejection results in allograft loss after liver cell transplantation

Liver Transplantation

Volumn 14, Issue 5, 2008, Pages 688-694

  Allen, Katrina J ^a,b,c,e   Mifsud, Nicole A ^d   Williamson, Robert ^b   Bertolino, Patrick ^e   Hardikar, Winita ^a,b,c  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BILIRUBIN; HLA ANTIGEN CLASS 1; HLA B39 ANTIGEN; HLA C7 ANTIGEN; PREDNISOLONE; TACROLIMUS;

ALLOGRAFT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD GROUP ABO SYSTEM; CASE REPORT; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CRIGLER NAJJAR SYNDROME; DRUG DOSE REDUCTION; ENZYME IMMUNOASSAY; FEMALE; HEPATOCYTE TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; LIVER GRAFT REJECTION; PHOTOTHERAPY; PLASMAPHERESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TREATMENT RESPONSE;

CHILD; CRIGLER-NAJJAR SYNDROME; FEMALE; GRAFT REJECTION; HEPATOCYTES; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; IMMUNITY, CELLULAR; LIVER TRANSPLANTATION; REOPERATION; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 43849107446     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21443     Document Type: Article

References (21)

1. Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338:1422-1427.
2. Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis 2006;29:431-435.
3. Allen KJ, Soriano HE, Liver cell transplantation: the road to clinical application. J Lab Clin Med 2001;138:298-312.
4. Bertolino P, Trescol-Biemont MC, Rabourdin-Combe C. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fall to promote survival. Eur J Immunol 1998;28:221-236.
5. Bertolino P, Trescol-Biemont MC, Thomas J, Fazekas de St Groth B, Pihlgren M, Marvel J, et al. Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol 1999,11:1225-1238.
6. Fisher RA, Strom SC. Human hepatocyte transplantation: worldwide results. Transplantation 2006;82:441-449.
7. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR. Genetic lesions of bilirubin uridinediphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat 2000:16:297-306.
8. Nydegger A, Bednarz A, Hardikar W. Use of daytime phototherapy for Crigler-Najjar disease. J Paediatr Child Health 2005;41:387-389.
9. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
10. O'Reilley J, Meyer B, Stoner W, Erber W, Hermann R, Davies J. Very early analysis of graft establishment after allogeneic BMT using the PCR. Br J Haematol 1993;85: 169-172.
11. Macdonald WA, Purcell AW, Mifsud NA, Ely LK, Williams DS, Chang L, et al. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med 2003; 198:679-691.
12. Benseler V, Bowen D, Shlitt H, Bishop A, McCaughan G, Bertolino P. The liver: a special case in transplantation tolerance. Semin Liver Dis 2007;27:194-213.
13. Bumgardner GL, Orosz CG. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells. Immunol Rev 2000;174:260-279.
14. Bertolino P, Bowen DG, McCaughan GW, Fazekas de St Groth B. Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol 2001;166:5430-5438.
15. Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004:114:701-712.
16. Lalor PF, Edwards S, McNab G, Salmi M, Jalkanen S, Adams DH. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol 2002;169:983-992.
17. Gao W, Demirci G, Li XC. Negative T cell costimulation and islet tolerance. Diabetes Metab Res Rev 2003;19:179-185.
18. Gao D, Li J, Orosz CG, Bumgardner GL. Different costimulation signals used by CD4+ and CD8+ cells that independently initiate rejection of allogeneic hepatocytes in mice. Hepatology 2000;32:1018-1028.
19. Bumgardner GL, Li J, Apte S, Heininger M, Frankel WL. Effect of tumor necrosis factor alpha and intercellular adhesion molecule-1 expression on immunogenicity of murine liver cells in mice. Hepatology 1998;28:466-474.
20. Lunsford KE, Home PH, Koester MA, Eiring AM, Walker JP, Dziema HL, Bumgardner GL. Activation and maturation of alloreactive CD4-independent, CD8+ cytolytic T cell. Am J Transplant 2006;6:2268-2281.
21. Zemmour J, Little AM, Schendel DJ, Parham P. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J Immunol 1992;148:1941-1948.